| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.2M | +36.7% |
| Cost of Revenue | $7.7M | +85.0% |
| Gross Profit | $1.4M | -42.6% |
| R&D Expense | $382K | +56.2% |
| SG&A Expense | $3.5M | -10.8% |
| Operating Income | -$6.2M | -196.9% |
| Interest Expense | $128K | -1.4% |
| Net Income | -$6.2M | -391.6% |
| EPS (Basic) | -$0.48 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.8M | -49.2% |
| Accounts Receivable | $126K | -89.7% |
| Inventory | $1.0M | +48.6% |
| Current Assets | $4.4M | -43.0% |
| Total Assets | $5.1M | -47.6% |
| Current Liabilities | $2.6M | +71.9% |
| Total Liabilities | $2.6M | +66.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.6M | -42.2% |
| Capital Expenditures | $13K | -91.4% |
| Investing Cash Flow | -$13K | +91.4% |
| Financing Cash Flow | $5K | -99.9% |
| Free Cash Flow | -$2.7M | -32.2% |
| -380.0% |
| Stockholders' Equity |
| $2.5M |
| -69.2% |